News tagged with merck
Facebook sidelines contested Merck profile page
Facebook will sideline a Merck page at the social network until a pair of US and German companies work out which one gets the online address, a source familiar with the matter told AFP.
Nov 29, 2011 |
not rated yet |
0
Merck will pay $950M to settle Vioxx investigation
(AP) -- The Department of Justice said Tuesday that drugmaker Merck will pay $950 million to resolve investigations into its marketing of the painkiller Vioxx.
Medicine & Health / Medications
Nov 22, 2011 |
not rated yet |
0
FDA backs Vytorin for kidney disease patients
(AP) -- The Food and Drug Administration says Merck's cholesterol drug Vytorin helps reduce heart attack, stroke and related problems in patients with kidney disease, a potential new use for the blockbuster drug.
Medicine & Health / Medications
Oct 31, 2011 |
not rated yet |
0
FDA approves first diabetes-cholesterol combo pill
(AP) -- The first combination pill for the millions of people with the dangerous combination of diabetes and high cholesterol won U.S. approval Friday, offering convenience - and savings - to patients taking multiple pills.
Medicine & Health / Medications
Oct 07, 2011 |
not rated yet |
0
Older pills often safer; many think new is better
Many consumers mistakenly believe new prescription drugs are always safer than those with long track records, and that only extremely effective drugs without major side effects win government approval, according to a new ...
Medicine & Health / Medications
Sep 12, 2011 |
3 / 5 (3) |
0
Faulty gene connected to ovarian cancer risk
In a new study published in Nature Genetics researchers say that women who possess a fault in a gene named RAD51D have a greater risk of developing ovarian cancer than women who do not have this fault and tests are expect ...
Aug 09, 2011 |
not rated yet |
0
|
New way of synthesizing organic chemicals mimics nature
Organic chemists have found a new way of synthesizing multiple complex organic molecules that until now have needed to be synthesized using time-consuming methods. The new strategy, which mimics natural biosynthesis methods, ...
Jul 15, 2011 |
4.8 / 5 (5) |
0
|
Teens look to parents more than friends for sexual role models
The results of a national online study show that 45% consider their parents to be their sexuality role model. Shattering stereotypes that parents and society hold about teen sexuality, the survey also revealed that only 32% ...
Jun 15, 2011 |
4 / 5 (1) |
0
FDA links some prostate drugs to cancer risk
(AP) -- The Food and Drug Administration expanded the warning label on a group of prostate drugs Thursday, saying they may increase the risk of a more serious form of prostate cancer.
Medicine & Health / Medications
Jun 09, 2011 |
3 / 5 (1) |
0
UNICEF discloses vaccine prices for 1st time
UNICEF is for the first time publicizing what drugmakers charge it for vaccines, as the world's biggest buyer of lifesaving immunizations aims to spark price competition in the face of rising costs.
Medicine & Health / Medications
May 29, 2011 |
5 / 5 (3) |
1
FDA says Vertex hepatitis drug is highly effective
(AP) -- Federal health officials say a highly anticipated hepatitis C drug from Vertex Pharmaceuticals successfully treats a clear majority of patients in less time than older medicines that have been used for 20 years.
Medicine & Health / Medications
Apr 26, 2011 |
not rated yet |
1
FDA says Merck drug successfully fights hepatitis
Federal health officials said Monday a highly-anticipated drug to treat hepatitis C made by Merck appears to cure more patients in less time than established drugs that have been used for 20 years. But the agency has questions ...
Medicine & Health / Medications
Apr 25, 2011 |
not rated yet |
0
Merck pays J&J $500mn in drug row settlement
Merck said Friday it has agreed to pay fellow US pharmaceutical giant Johnson & Johnson $500 million to end a two-year tussle over profit-sharing deals for two anti-inflammatory drugs.
Medicine & Health / Medications
Apr 15, 2011 |
not rated yet |
1
Merck says US rejects its MS drug
German pharmaceutical group Merck KgaA said Wednesday that the US Food and Drug Administration (FDA) has refused to approve use of its multiple sclerosis treatment Cladribine.
Medicine & Health / Medications
Mar 02, 2011 |
5 / 5 (1) |
0
New hope for hepatitis C, an often hidden disease
There's new hope for an overlooked epidemic: Two powerful drugs are nearing the market that promise to help cure many more people of liver-attacking hepatitis C - even though most who have the simmering infection ...
Jan 17, 2011 |
4.3 / 5 (6) |
3
